| MRSN |
Mersana Therapeutics, Inc. |
06 Jan 2026 |
13 |
$0 |
4 |
Director |
06 Jan 2026, 18:32 |
| MRSN |
Mersana Therapeutics, Inc. |
12 Jun 2025 |
1 |
$0 |
4 |
Director |
13 Jun 2025, 17:10 |
| NUVL |
Nuvalent, Inc. |
11 Dec 2024 |
1 |
-$110,000,000 |
4 |
Director |
13 Dec 2024, 16:30 |
| NUVL |
Nuvalent, Inc. |
12 Jun 2024 |
2 |
$0 |
4 |
Director |
14 Jun 2024, 16:53 |
| MRSN |
Mersana Therapeutics, Inc. |
11 Jun 2024 |
1 |
$0 |
4 |
Director |
12 Jun 2024, 17:31 |
| NUVL |
Nuvalent, Inc. |
27 Mar 2024 |
2 |
-$64,035,959 |
4 |
Director |
29 Mar 2024, 17:15 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
08 Aug 2023 |
1 |
-$21,585,000 |
4 |
Director |
10 Aug 2023, 16:31 |
| NUVL |
Nuvalent, Inc. |
15 Jun 2023 |
1 |
$0 |
4 |
Director |
16 Jun 2023, 17:08 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
14 Jun 2023 |
1 |
-$6,340,000 |
4 |
Director |
16 Jun 2023, 16:30 |
| MRSN |
Mersana Therapeutics, Inc. |
08 Jun 2023 |
2 |
$0 |
4 |
Director |
12 Jun 2023, 17:25 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
26 May 2023 |
2 |
$0 |
4 |
Director |
31 May 2023, 17:43 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
18 May 2023 |
1 |
-$10,550,000 |
4 |
Director |
19 May 2023, 16:30 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
06 Dec 2022 |
1 |
-$17,400,000 |
4 |
Director |
08 Dec 2022, 15:41 |
| NUVL |
Nuvalent, Inc. |
03 Nov 2022 |
1 |
+$4,999,976 |
4 |
Director |
03 Nov 2022, 16:15 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
15 Aug 2022 |
1 |
-$44,040,000 |
4 |
Director |
17 Aug 2022, 17:17 |
| NUVL |
Nuvalent, Inc. |
16 Jun 2022 |
1 |
$0 |
4 |
Director |
17 Jun 2022, 17:13 |
| MRSN |
Mersana Therapeutics, Inc. |
09 Jun 2022 |
1 |
$0 |
4 |
Director |
10 Jun 2022, 17:25 |
| MRSN |
Mersana Therapeutics, Inc. |
31 May 2022 |
2 |
+$311,958 |
4 |
Director |
02 Jun 2022, 18:17 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
26 May 2022 |
2 |
$0 |
4 |
Director |
27 May 2022, 17:29 |
| MRSN |
Mersana Therapeutics, Inc. |
24 May 2022 |
3 |
+$854,175 |
4 |
Director |
26 May 2022, 18:02 |
| MRSN |
Mersana Therapeutics, Inc. |
19 May 2022 |
3 |
+$746,437 |
4 |
Director |
23 May 2022, 17:49 |
| MRSN |
Mersana Therapeutics, Inc. |
16 May 2022 |
3 |
+$1,137,660 |
4 |
Director |
18 May 2022, 18:19 |
| MRSN |
Mersana Therapeutics, Inc. |
13 Apr 2022 |
1 |
+$2,500,000 |
4 |
Director |
14 Apr 2022, 16:59 |
| MRSN |
Mersana Therapeutics, Inc. |
12 Apr 2022 |
1 |
+$2,499,880 |
4 |
Director |
13 Apr 2022, 18:27 |
| MRSN |
Mersana Therapeutics, Inc. |
07 Feb 2022 |
1 |
+$5,022,724 |
4 |
Director |
08 Feb 2022, 16:04 |
| MRSN |
Mersana Therapeutics, Inc. |
03 Jan 2022 |
1 |
$0 |
4 |
Director |
05 Jan 2022, 17:47 |
| MRSN |
Mersana Therapeutics, Inc. |
30 Dec 2021 |
1 |
+$5,012,250 |
4 |
Director |
04 Jan 2022, 17:16 |
| MRSN |
Mersana Therapeutics, Inc. |
29 Dec 2021 |
1 |
+$5,031,250 |
4 |
Director |
03 Jan 2022, 17:28 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
27 Aug 2021 |
3 |
-$32,440,000 |
4 |
Director |
27 Aug 2021, 20:07 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
09 Aug 2021 |
3 |
-$24,300,000 |
4 |
Director |
11 Aug 2021, 18:26 |
| NUVL |
Nuvalent, Inc. |
02 Aug 2021 |
3 |
+$12,495,000 |
4 |
Director |
04 Aug 2021, 17:12 |
| NUVL |
Nuvalent, Inc. |
28 Jul 2021 |
1 |
$0 |
4 |
Director |
30 Jul 2021, 17:57 |
| NUVL |
Nuvalent, Inc. |
28 Jul 2021 |
0 |
$0 |
3 |
Director |
28 Jul 2021, 21:29 |
| MRSN |
Mersana Therapeutics, Inc. |
11 Jun 2021 |
1 |
$0 |
4 |
Director |
15 Jun 2021, 18:35 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
10 Jun 2021 |
1 |
$0 |
4 |
Director |
11 Jun 2021, 17:23 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
28 May 2021 |
1 |
$0 |
4 |
Director |
02 Jun 2021, 19:00 |